These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24004)

  • 1. Adoptive immunochemotherapy of a transplantable AKR leukemia (K36).
    Putman DL; Kind PD; Goldin A; Kende M
    Int J Cancer; 1978 Feb; 21(2):230-3. PubMed ID: 24004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Flinton LJ; Simon JD; Kelley RJ; Albala MM
    Cancer Res; 1977 Oct; 37(10):3494-6. PubMed ID: 20223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M; Keys LD; Gaston M; Goldin A
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
    Bortin MM; Rimm AA; Rodey GE; Giller R; Saltzstein EC
    Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270
    [No Abstract]   [Full Text] [Related]  

  • 6. Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice.
    Bortin MM; Rose WC; Truitt RL; Rimm AA; Saltzstein EC; Rodey GE
    J Natl Cancer Inst; 1975 Nov; 55(5):1227-9. PubMed ID: 1546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy and combined chemo-immunotherapy in transplantable leukaemia of AKR mice (TAL); occurrence of natural killers.
    Schneiberg K; Rytwiński K; Tabeńska J
    Haematologia (Budap); 1981; 14(2):137-46. PubMed ID: 7274781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems.
    Fefer A; Einstein AB; Cheever MA
    Ann N Y Acad Sci; 1976; 277(00):492-504. PubMed ID: 793486
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):634-6. PubMed ID: 234788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft versus leukemia: quantification of adoptive immunotherapy in murine leukemia.
    Bortin MM; Rimm AA; Saltzstein EC
    Science; 1973 Feb; 179(4075):811-3. PubMed ID: 4405359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review.
    Fefer A
    Isr J Med Sci; 1973 Mar; 9(3):350-65. PubMed ID: 4145461
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
    Hui KM; Sim T; Foo TT; Oei AA
    J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
    Palmer AM; Symes MO
    Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
    [No Abstract]   [Full Text] [Related]  

  • 16. Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice.
    Bortin MM; Truitt RL; Rose WC; Rimm AA; Saltzstein EC
    Adv Exp Med Biol; 1976; 73 Pt B():331-9. PubMed ID: 793340
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma.
    Truitt RL; Rimm AA; Saltzstein EC; Rose WC; Bortin MM
    Transplant Proc; 1976 Dec; 8(4):569-74. PubMed ID: 11589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide.
    Truitt RL; Rose WC; Rimm AA; Bortin MM
    Exp Hematol; 1978 May; 6(5):488-98. PubMed ID: 26584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of the antileukemic activity in nonimmune allogeneic splenocytes using spleen hemoregulators].
    Svirnovskiĭ AI; Shimanskaia TV; Bakun AV; Ageĭchik VM
    Eksp Onkol; 1988; 10(5):57-61. PubMed ID: 3208692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells.
    Bortin MM; Rimm AA; Rose WC; Saltzstein EC
    Transplantation; 1974 Sep; 18(3):280-3. PubMed ID: 4154022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.